The cost-effectiveness of rituximab, cyclophosphamide, vincristine and prednisolone (RCVP) compared with CVP for the treatment of follicular non-Hodgkin\u27s lymphoma (NHL) in the UK

Authors
Publication date
Publisher
Blood, American Society of Hematology

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Newcastle University E-Prints

    redirect
    oaioai:eprints.ncl.ac.uk:133170
    Last time updated on 30/05/2021